Keppra promising for newly diagnosed epilepsy

... NEW YORK (Reuters Health) - Treatment with low doses of levetiracetam, the active ingredient in the drug Keppra, appears to be effective by itself for controlling newly diagnosed epilepsy, new research indicates. Rates of freedom from seizures with levetiracetam were comparable to those seen with a gold-standard therapy, controlled-release carbamazepine. ...